Serratus Posterior Superior Intercostal Plane Block Versus Suprascapular Nerve Block and Axillary Nerve Block for Analgesia in Shoulder Arthroscopic Surgery

NCT06997601 | Completed

• 1 other identifier: 36264PR1191/4/25
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare the serratus posterior superior intercostal plane block and suprascapular nerve block and axillary nerve block for analgesia in shoulder arthroscopic surgery.

Conditions

Serratus Posterior Superior Intercostal Plane Block; Suprascapular Nerve Block; Axillary Nerve Block; Analgesia; Shoulder Arthroscopic Surgery

Outcome Measures

Primary Outcomes (1)

• Time to the 1st rescue analgesia

  Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administered).

  24 hours postoperatively

Secondary Outcomes (4)

• Degree of pain

  24 hours postoperatively

• Intraoperative fentanyl consumption

  Intraoperatively

• Total morphine consumption

  24 hours postoperatively

• Incidence of adverse events

  24 hours postoperatively

Study Arms (2)

Group SPSIPB

EXPERIMENTAL

Patients will receive a serratus posterior superior intercostal plane block.

Other: Serratus posterior superior intercostal plane block

Group SSSB+ANB

EXPERIMENTAL

Patients will receive suprascapular nerve block + axillary nerve block.

Other: Suprascapular nerve block + Axillary nerve block

Interventions

Serratus posterior superior intercostal plane block OTHER

Patients will receive a serratus posterior superior intercostal plane block.

Group SPSIPB

Suprascapular nerve block + Axillary nerve block OTHER

Patients will receive suprascapular nerve block + axillary nerve block.

Group SSSB+ANB

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiology (ASA) physical status I-II.
• Scheduled for open thoracotomy.

You may not qualify if:

• Infection at the site of regional blocks.
• Allergy to any drug used in this study.
• Use of psychotropic and/or narcotic medications on a regular basis.
• Cognitive dysfunction.
• Cardiovascular disease.
• Pulmonary disease.
• Coagulation abnormalities.
• Anatomical abnormalities.
• Neuropathic pain.
• Body mass index \>40.
• History of substance abuse.
• Previous surgery in the same shoulder.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

• First Submitted: May 21, 2025
• First Posted: May 30, 2025
• Study Start: May 31, 2025
• Primary Completion: November 1, 2025
• Study Completion: November 1, 2025
• Last Updated: November 25, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author.

Locations

EG (1)